Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Controlled Clinical Trial
. 2018 Oct 17;10(10):1526.
doi: 10.3390/nu10101526.

Eleven Weeks of Iron Supplementation Does Not Maintain Iron Status for an Entire Competitive Season in Elite Female Volleyball Players: A Follow-Up Study

Affiliations
Controlled Clinical Trial

Eleven Weeks of Iron Supplementation Does Not Maintain Iron Status for an Entire Competitive Season in Elite Female Volleyball Players: A Follow-Up Study

Juan Mielgo-Ayuso et al. Nutrients. .

Abstract

Background: Even though iron supplementation can be effective, it is necessary to be cautious of toxicity and aim to do no harm, therefore, it is important to examine the length of time the benefits of iron supplementation can be maintained following its cessation. The main purpose of this study was to analyze if iron stores and strength performance were maintained in elite female volleyball players for the final 18 weeks of a competitive season following the cessation of 11 weeks of iron supplementation.

Methods: Twenty-two volleyballers (age: 27.0 ± 5.6 years.) were assigned to two groups (iron treatment group-ITG, n = 11 or control gropu-CG, n = 11) at the beginning of a previous trial (T0) and ITG consumed 325mg/d of ferrous sulphate for 11 weeks (T11). Then, in the present study iron status and strength were measured again 10 (T21) and 18 weeks later (T29) after the cessation of supplementation.

Results: At the end of the previous trial (T11), ITG maintained iron status as measured by hematological parameters (serum iron-sFE, serum ferritin-FER, transferrin saturation index-TSI, and hemogloblin-Hb), however, CG showed a decrease in these markers at T11. Further, from T0 to T11 ITG experienced greater (p < 0.05) changes in clean and jerk, power clean, and total mean strength (TMS-sum of all strength tests) than CG. In the present, follow-up investigation, there was a group-by-time interaction in favor of CG vs. ITG from T11 to T21 for FER (p = 0.028) and Hb (p = 0.042). Further, there was an increase for CG (p < 0.001) in power clean for CG from T11 (38.4 ± 1.7 kg) to T21 (41.3 ± 1.9 kg) and T29 (41.8 ± 1.7 kg), but no change for power clean in ITG (p > 0.05). A group-by-time interaction from T11 to T29 occurred in favor of CG for half-squat (p = 0.049) and TMS (p = 0.049).

Conclusion: Our findings suggest that the benefits of iron supplementation are not sustained in elite female volleyballers if supplementation is ceased for 18 weeks.

Keywords: exercise; female; health; iron supplementation; volleyball eleven weeks of iron supplementation does not maintain iron status for an entire competitive.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Time and type of training performed by volleyball players in each week of study.
Figure 2
Figure 2
Hematological parameters in control group (CG) and iron treatment group (ITG) during follow up study. Data are expressed as mean and standard error. p(TxG) indicates interaction between treatment and time. * Significant differences between groups. a: Significant differences from T11.
Figure 3
Figure 3
Changes in Strength Performance Tests in control group (CG) and iron treatment group (ITG) at T11, T21, and T29. Data are expressed as mean and standard error. TMS: Sum of all strength tests divided by 6. p(TxG) indicates interaction between treatment and time. * Significant differences between groups.
Figure 4
Figure 4
Percentage changes during follow up on hematological parameters and strength performance tests in control group (CG) and iron treatment group (ITG). Data are expressed as means ± standard error. Δ (%): ((T29 − T11)/T11) × 100; FER= serum ferritin; Hb = hemoglobin; Hct = hematocrit; sFe = serum iron; TSI = transferrin saturation index; TMS = Total Mean Strength: Sum of all strength tests divided by 6. * Significantly different between groups, p < 0.05.

Similar articles

Cited by

References

    1. Hinton P.S. Iron and the Endurance Athlete. Appl. Physiol. Nutr. Metab. 2014;39:1012–1018. doi: 10.1139/apnm-2014-0147. - DOI - PubMed
    1. Shaskey D.J., Green G.A. Sports Haematology. Sports Med. 2000;29:27–38. doi: 10.2165/00007256-200029010-00003. - DOI - PubMed
    1. Ahmadi A., Enayatizadeh N., Akbarzadeh M., Asadi S., Tabatabaee S.H. Iron Status in Female Athletes Participating in Team Ball-Sports. Pak. J. Biol. Sci. 2010;13:93–96. doi: 10.3923/pjbs.2010.93.96. - DOI - PubMed
    1. Mielgo-Ayuso J., Urdampilleta A., Martinez-Sanz J.M., Seco J. Dietary Iron Intake and Deficiency in Elite Women Volleyball Players. Nutr. Hosp. 2012;27:1592–1597. - PubMed
    1. Brownlie T., 4th, Utermohlen V., Hinton P.S., Haas J.D. Tissue Iron Deficiency without Anemia Impairs Adaptation in Endurance Capacity After Aerobic Training in Previously Untrained Women. Am. J. Clin. Nutr. 2004;79:437–443. doi: 10.1093/ajcn/79.3.437. - DOI - PubMed

Publication types

MeSH terms